In response to a memo sent out from the FDA reminding employees to not disclose information outside of the FDA, Senator Grassley has sent a letter to acting chief of the FDA to remind them that interfering with whistle blowers is illegal.
Here is a link to the letter on the Senate Finance Committee website.
Letter
Senator Grassley is a long time advocate of whistle blower's rights. In the letter he makes the point that the memo last week from the FDA to employees was ill timed in the light of some recent investigations going on at the FDA:
"My concern is that this recent memorandum could be viewed by some as an effort to chill and/or prevent FDA employees from exercising their rights under whistleblower protection laws to communicate with Congress.
Fox example, internal FDA documents released recently seem to suggest that lobbying may have influenced the decision in a device approval.[1] Another internal document shows that a physician was removed for inappropriate reasons from a recent safety panel.[2] In both, cases, I do not believe that Congress would be notified unless whistleblowers spoke up. "
Senator Grassley is asking the acting Chief of the FDA to issue a second memorandum clarifying the situation and ensuring that would be whistle blowers are unencumbered in their rights to speak to congress and the FDA's obligation to honor those rights.
Let's keep an eye on this one...
Showing posts with label Grassley. Show all posts
Showing posts with label Grassley. Show all posts
Wednesday, March 25, 2009
Tuesday, February 10, 2009
PFIZER V. GRASSLEY
Disclosing Gifts to Docs
The WSJ Health blog has an interesting commentary on the difference between some of the plans for disclosure of gifts to docs put forward by companies and the plan advocated by Chuck Grassley.
http://blogs.wsj.com/health/2009/02/10/how-pfizers-doctor-payment-disclosure-compares-to-grassley-plan/
Some of the commenters point out that none of this would impact patients; they would not change docs or question a particular prescription.
I wonder if that is true. I'm not talking about the small sums, but if you knew your doc was receiving very significant moolah from this or that company, would it impact the way you viewed that practice and impact your experience and even choices as a patient?
The WSJ Health blog has an interesting commentary on the difference between some of the plans for disclosure of gifts to docs put forward by companies and the plan advocated by Chuck Grassley.
http://blogs.wsj.com/health/2009/02/10/how-pfizers-doctor-payment-disclosure-compares-to-grassley-plan/
Some of the commenters point out that none of this would impact patients; they would not change docs or question a particular prescription.
I wonder if that is true. I'm not talking about the small sums, but if you knew your doc was receiving very significant moolah from this or that company, would it impact the way you viewed that practice and impact your experience and even choices as a patient?
Subscribe to:
Posts (Atom)